Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: A pathologic analysis-Reference-Cited by-同舟云学术

Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: A pathologic analysis

Published:2004-11 Issue:3 Volume:60 Page:722-730
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Vicini Frank A.,Kestin Larry L.,Goldstein Neal S.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference16 articles.

1. Limited-field radiation therapy in the management of early-stage breast cancer;Vicini;J Natl Cancer Inst,2003

2. Workshop on partial breast irradiation;Wallner;J Natl Cancer Inst,2004

3. Factors associated with ipsilateral breast failure and distant metastases in patients with invasive breast carcinoma treated with breast-conserving therapy. A clinicopathologic study of 607 neoplasms from 583 patients;Goldstein;Am J Clin Pathol,2003

4. Effect of time interval between breast-conserving surgery and radiation therapy on ipsilateral breast recurrence;Froud;Int J Radiat Oncol Biol Phys,2000

5. Combined histologic and cytologic criteria for the diagnosis on mammary atypical ductal hyperplasia;Page;Hum Pathol,1992

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the adaptive advantage: correlation and machine learning classification to identify optimal online adaptive stereotactic partial breast candidates;Physics in Medicine & Biology;2024-05-30

2. Changes in approach to locoregional treatment of early breast cancer;Onkologie;2024-02-28

3. Accelerated Partial Breast Irradiation for HER2-Positive Early-Stage Breast Cancer;International Journal of Radiation Oncology*Biology*Physics;2024-02

4. Accelerated partial breast irradiation: Current evidence and future developments;Cancer Innovation;2024-01-22

5. MR-LINAC, a New Partner in Radiation Oncology: Current Landscape;Cancers;2024-01-08